A landmark French trial will seek to settle one of the country’s biggest pharmaceutical scandals, probing whether the company behind a weight-loss drug believed to have triggered killer side effects covered up the risks.
Sanofi said a reorganization of the company’s research and development operation in Germany and France would result in 466 job cuts in the two countries.
U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation aimed at lowering the cost of prescription drugs for U.S. consumers.
French drugmaker Ipsen plans to bring in multiple new medicines through a series of transactions and sees the recent price drop of biotech stocks as increasing deal opportunities, according to the company’s chief executive.
France’s competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) after it ruled the company had deliberately slowed market access to generic copies of its painkiller Durogesic.
Sanofi is investing invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of the company’s influenza vaccines.
Nestle plans to cut up to 450 jobs at a Galderma research and development center in southern France, the Swiss company said.
Drug maker Servier and the French drug regulator will face trial over weight-loss pill Mediator, believed to have caused at least 500 deaths in one of France’s worst health scandals, the prosecutor’s office said.
Surgeons re-attached a woman’s arms after they were severed by a train, a rare operation and a first in France in that both limbs were worked on at the same time.
The UK Supreme Court ruled that generic drugmaker Actavis’ versions of the cancer drug Alimta directly infringe on certain Eli Lilly patents in Europe.